Enliven Therapeutics, Inc.
ELVN
$20.63
$0.3051.50%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 57.02% | -9.66% | 23.82% | 10.76% | 12.43% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -9.92% | -28.28% | 57.10% | -0.37% | 7.02% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -99.46% | -- | -- |
Total Current Assets | 55.79% | -12.72% | 19.53% | 10.57% | 12.34% |
|
|||||
Total Current Assets | 55.79% | -12.72% | 19.53% | 10.57% | 12.34% |
Net Property, Plant & Equipment | 29.71% | 14.18% | -56.87% | -47.67% | -41.06% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -10.90% | 54.64% | 54.17% | 84.42% | 103.94% |
Total Assets | 54.07% | -11.73% | 19.82% | 11.45% | 13.36% |
|
|||||
Total Accounts Payable | 117.08% | -42.72% | 152.26% | -31.75% | -61.91% |
Total Accrued Expenses | 9.32% | 2.52% | -2.01% | 58.88% | 115.07% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 122.49% | 44.84% | -- | -74.40% | -48.63% |
Total Finance Division Other Current Liabilities | -99.34% | -98.60% | -98.03% | -41.30% | 1,271.53% |
Total Other Current Liabilities | -99.34% | -98.60% | -98.03% | -41.30% | 1,271.53% |
Total Current Liabilities | -31.19% | -44.18% | -38.54% | 40.96% | 141.66% |
|
|||||
Total Current Liabilities | -31.19% | -44.18% | -38.54% | 40.96% | 141.66% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -98.33% |
Total Liabilities | -30.28% | -43.05% | -38.70% | 38.51% | 132.58% |
|
|||||
Common Stock & APIC | 56.51% | 13.21% | 38.24% | 28.08% | 27.65% |
Retained Earnings | -50.84% | -53.52% | -57.64% | -63.09% | -72.46% |
Treasury Stock & Other | -27.34% | 69.81% | -60.99% | 264.63% | -25.23% |
Total Common Equity | 60.19% | -9.26% | 26.00% | 10.18% | 9.30% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 60.19% | -9.26% | 26.00% | 10.18% | 9.30% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 60.19% | -9.26% | 26.00% | 10.18% | 9.30% |
|